tibolone has been researched along with hydroxyproline in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schreiber, V; Stĕpán, JJ | 1 |
| Hosoi, T; Ikegami, A; Kasugai, Y; Matsuo, K; Ohashi, M; Orimo, H; Ouchi, Y; Sukamoto, T | 1 |
| Alhava, E; Arnala, I; Jääskeläinen, K; Kröger, H; Parviainen, MT | 1 |
| Bigler, JM; Burckhardt, P; Landry, M; Pache, T; Renteria, S; Thiébaud, D; Welti, HJ | 1 |
| Akgul, C; Canbaz, M; Vural, P | 1 |
2 trial(s) available for tibolone and hydroxyproline
| Article | Year |
|---|---|
Urinary bone resorption markers in monitoring treatment of symptomatic osteoporosis.
Topics: Aged; Anabolic Agents; Biomarkers; Bone Resorption; Calcium; Collagen; Collagen Type I; Double-Blind Method; Female; Humans; Hydroxyproline; Immunoenzyme Techniques; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Peptides; Placebos; Pyridines | 1999 |
A 3-year study of prevention of postmenopausal bone loss: conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone.
Topics: Absorptiometry, Photon; Alkaline Phosphatase; Animals; Bone Density; Calcium; Creatinine; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Femur; Horses; Humans; Hydroxyproline; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Lumbar Vertebrae; Medroxyprogesterone Acetate; Norpregnenes; Osteocalcin; Osteoporosis, Postmenopausal | 1998 |
3 other study(ies) available for tibolone and hydroxyproline
| Article | Year |
|---|---|
Anabolic effects of progestogens in bone remodelling.
Topics: Alkaline Phosphatase; Bone and Bones; Bone Density; Bone Remodeling; Estradiol; Female; Follow-Up Studies; Humans; Hydroxyproline; Norethindrone; Norpregnenes; Osteoporosis; Ovariectomy; Progestins; Prospective Studies | 1995 |
Effects of tibolone (Org OD14) treatment for 3 months on ovariectomy-induced osteopenia in 8-month-old rats on a low-calcium diet: preventive testing for 3 months.
Topics: Administration, Oral; Amino Acids; Anabolic Agents; Animals; Antineoplastic Agents, Hormonal; Biomarkers; Bone Density; Bone Diseases, Metabolic; Bone Resorption; Calcium; Cholesterol; Creatinine; Female; Femur; Humans; Hydroxyproline; Lumbar Vertebrae; Norpregnenes; Osteocalcin; Ovariectomy; Rats; Rats, Sprague-Dawley; Weight Gain | 1998 |
Effects of menopause and postmenopausal tibolone treatment on plasma TNFalpha, IL-4, IL-10, IL-12 cytokine pattern and some bone turnover markers.
Topics: Adult; Biomarkers; Bone Resorption; Calcium; Cytokines; Female; Humans; Hydroxyproline; Middle Aged; Norpregnenes; Postmenopause; Premenopause | 2006 |